SGLT-2 Inhibition Beyond Glycemic Control: Exploring the Neuroprotective Properties of Dapagliflozin in Diabetes-Related Neurodegeneration . CDF 2024, 53 (03), 6207-6213. https://doi.org/10.48047/mbw59m89.